Publication | Closed Access

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Rheumatoid DisorderRheumatologyTofacitinib MonotherapyMedicineRheumatic DiseasesClinical TrialsInflammatory Rheumatic DiseasePharmacotherapyOral StrategyPharmacologyRheumatoid Arthritis